market access

NHS to reimburse Gilead’s CAR-T in adults

https://pharmaphorum.com/news/nhs-to-reimburse-gileads-car-t-in-adults/

Merck & Co signs biosimilars deal for US veterans

https://pharmaphorum.com/news/merck-co-signs-biosimilars-deal-for-us-veterans/

Digital technology could revolutionise drug reimbursement in Spain

https://pharmaphorum.com/news/digital-technology-could-revolutionise-drug-reimbursement-in-spain/

Patients call for end to CF drug price row at key meeting

https://pharmaphorum.com/news/patients-call-for-cf-drug-price-agreement-ahead-of-meeting/

Gilead launches generics of own hepatitis C drugs in US to cut health costs

https://pharmaphorum.com/news/gilead-launches-generics-of-own-hepatitis-c-drugs-in-us-to-cut-health-costs/

Only 4 Weeks Until Orphan Drugs & Rare Diseases 2018

https://pharmaphorum.com/partner-content/only-4-weeks-until-orphan-drugs-rare-diseases-2018/

NICE rejects Novartis’ CAR-T in adult lymphoma

https://pharmaphorum.com/news/nice-rejects-novartis-car-t-in-adult-leukaemia/

UK ‘less interesting’ to pharma because of Brexit – Roche CEO

https://pharmaphorum.com/news/uk-less-interesting-to-pharma-because-of-brexit-roche-ceo/

Roche calls for talks after NICE rejects drug for progressive MS

https://pharmaphorum.com/news/roche-calls-for-talks-after-nice-rejects-ocrevus/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search